Last reviewed · How we verify
NCT04074486: BSC-CI-NPC
Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC
trial testing BrainScope Ahead 300iP-O in Brain Injuries in 1,318 participants. Completed in 31 March 2022.
31 January 2022
Quick facts
| Lead sponsor | BrainScope Company, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,318 |
| Start date | 2 October 2019 |
| Primary completion | 31 January 2022 |
| Estimated completion | 31 March 2022 |
| Sites | 6 locations across United States |
Drugs / interventions tested
- BrainScope Ahead 300iP-O
- SCAT5
- Near Point Convergence
Conditions studied
- Brain Injuries — all drugs for Brain Injuries →
- Concussion, Mild — all drugs for Concussion, Mild →
- Concussion, Brain — all drugs for Concussion, Brain →
- Near Point Convergence — all drugs for Near Point Convergence →
Sponsor
BrainScope Company, Inc.
Who can join
Adults 13 to 50, any sex, with Brain Injuries or Concussion, Mild. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is designed to collect data which will be used to associate changes in EEG, neurocognitive performance, eNPC and clinical symptoms in concussion subtypes. The study will recruit males and females, 13-50 years old, from Concussion Centers/Programs, Sports Venues and Emergency Departments (ED) across the country, over an 18-month period (Phase 2, 12 months for Algorithm Development and Norming, and Phase 3, 6 months for Validation).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04074486
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Brain Injuries
Currently open trials in the same condition.
- NCT06607523 — The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms · NA · recruiting
- NCT06873477 — Evaluation of Patients Affected by Traumatic and Hypoxic-ischemic Brain Injury · recruiting
- NCT06511804 — Correlation Between Noninvasive Blood Vessel Functionality Parameters and Cerebral Hemodynamics in Neurocritical Care Pa · recruiting
- NCT06863025 — Effects of Neurofeedback Training on Attentional Deficits in Patients With Acquired Brain Injury · NA · active not recruiting
- NCT06571032 — Electroencephalography in the Management of Neuroelectric Stimulation in Patients With Severe Traumatic Brain Injuries · recruiting
Other BrainScope Company, Inc. trials
Trials by the same sponsor.
- NCT04279431 — Follow-up of MTBI Patients Discharged from the ED Using Standard Clinical Triage Including BrainScope One · active not recruiting
- NCT03671083 — Validation of Brain Function Assessment Algorithm for mTBI/Concussion · completed
- NCT03963804 — Objective Brain Function Assessment of mTBI/Concussion · completed
- NCT02957461 — Validation of Brain Function Assessment Algorithm for mTBI/Concussion in College Athletes · completed
- NCT02661633 — Objective Brain Function Assessment of mTBI/Concussion in High School Athletes · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04074486 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by BrainScope Company, Inc.
- Last refreshed: 10 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04074486.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing